Loading...
Reviewing the Pathophysiology Behind the Advances in the Management of Giant Cell Arteritis
Improving understanding of the underlying pathophysiology of giant cell arteritis (GCA) is transforming clinical management by identifying novel avenues for targeted therapies. One key area of concern for both clinicians and patients with GCA is glucocorticoid (GC) morbidity. The first randomised co...
Saved in:
| Published in: | Ophthalmol Ther |
|---|---|
| Main Authors: | , , , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Springer Healthcare
2019
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6513947/ https://ncbi.nlm.nih.gov/pubmed/30820767 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40123-019-0171-0 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|